UniProt ID | MLKL_HUMAN | |
---|---|---|
UniProt AC | Q8NB16 | |
Protein Name | Mixed lineage kinase domain-like protein | |
Gene Name | MLKL {ECO:0000312|EMBL:AAH28141.1} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 471 | |
Subcellular Localization | Cytoplasm . Cell membrane . Localizes to the cytoplasm and translocates to the plasma membrane on necroptosis induction. | |
Protein Description | Pseudokinase that plays a key role in TNF-induced necroptosis, a programmed cell death process. Activated following phosphorylation by RIPK3, leading to homotrimerization, localization to the plasma membrane and execution of programmed necrosis characterized by calcium influx and plasma membrane damage. Does not have protein kinase activity.. | |
Protein Sequence | MENLKHIITLGQVIHKRCEEMKYCKKQCRRLGHRVLGLIKPLEMLQDQGKRSVPSEKLTTAMNRFKAALEEANGEIEKFSNRSNICRFLTASQDKILFKDVNRKLSDVWKELSLLLQVEQRMPVSPISQGASWAQEDQQDADEDRRAFQMLRRDNEKIEASLRRLEINMKEIKETLRQYLPPKCMQEIPQEQIKEIKKEQLSGSPWILLRENEVSTLYKGEYHRAPVAIKVFKKLQAGSIAIVRQTFNKEIKTMKKFESPNILRIFGICIDETVTPPQFSIVMEYCELGTLRELLDREKDLTLGKRMVLVLGAARGLYRLHHSEAPELHGKIRSSNFLVTQGYQVKLAGFELRKTQTSMSLGTTREKTDRVKSTAYLSPQELEDVFYQYDVKSEIYSFGIVLWEIATGDIPFQGCNSEKIRKLVAVKRQQEPLGEDCPSELREIIDECRAHDPSVRPSVDEILKKLSTFSK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
16 | Acetylation | TLGQVIHKRCEEMKY HHHHHHHHHHHHHHH | 47.85 | 26051181 | |
22 | Ubiquitination | HKRCEEMKYCKKQCR HHHHHHHHHHHHHHH | 51.26 | 24816145 | |
40 | Ubiquitination | HRVLGLIKPLEMLQD HHHHHHHHHHHHHHH | 48.90 | 29967540 | |
50 | Ubiquitination | EMLQDQGKRSVPSEK HHHHHCCCCCCCHHH | 35.55 | 33845483 | |
52 | Phosphorylation | LQDQGKRSVPSEKLT HHHCCCCCCCHHHHH | 41.69 | 23403867 | |
55 | Phosphorylation | QGKRSVPSEKLTTAM CCCCCCCHHHHHHHH | 45.25 | 23403867 | |
57 | Ubiquitination | KRSVPSEKLTTAMNR CCCCCHHHHHHHHHH | 56.31 | 24816145 | |
59 | Phosphorylation | SVPSEKLTTAMNRFK CCCHHHHHHHHHHHH | 24.47 | 23403867 | |
60 | Phosphorylation | VPSEKLTTAMNRFKA CCHHHHHHHHHHHHH | 34.05 | 23403867 | |
66 | Acetylation | TTAMNRFKAALEEAN HHHHHHHHHHHHHHC | 29.52 | 26051181 | |
66 | Ubiquitination | TTAMNRFKAALEEAN HHHHHHHHHHHHHHC | 29.52 | 29967540 | |
78 | Ubiquitination | EANGEIEKFSNRSNI HHCCHHHHHCCCCCH | 60.81 | 29967540 | |
92 | Phosphorylation | ICRFLTASQDKILFK HHHHHHCCCCCEEHH | 33.41 | 25159151 | |
95 | Acetylation | FLTASQDKILFKDVN HHHCCCCCEEHHHHC | 33.40 | 25953088 | |
106 | Phosphorylation | KDVNRKLSDVWKELS HHHCHHHHHHHHHHH | 32.90 | 20873877 | |
125 | Phosphorylation | VEQRMPVSPISQGAS HHHHCCCCCCCCCCC | 15.62 | 25159151 | |
128 | Phosphorylation | RMPVSPISQGASWAQ HCCCCCCCCCCCHHH | 26.41 | 21815630 | |
132 | Phosphorylation | SPISQGASWAQEDQQ CCCCCCCCHHHHHHC | 29.75 | 22468782 | |
157 | Ubiquitination | MLRRDNEKIEASLRR HHHHCHHHHHHHHHH | 52.69 | 29967540 | |
157 | Acetylation | MLRRDNEKIEASLRR HHHHCHHHHHHHHHH | 52.69 | 25953088 | |
161 | Phosphorylation | DNEKIEASLRRLEIN CHHHHHHHHHHHHCC | 15.04 | 29514088 | |
173 | Ubiquitination | EINMKEIKETLRQYL HCCHHHHHHHHHHHC | 45.82 | 29967540 | |
183 | Ubiquitination | LRQYLPPKCMQEIPQ HHHHCCHHHHCCCCH | 40.16 | 29967540 | |
198 | Ubiquitination | EQIKEIKKEQLSGSP HHHHHHHHHHHCCCC | 57.25 | 29967540 | |
215 | Phosphorylation | LLRENEVSTLYKGEY EEECCCCCCCCCCCC | 13.40 | 30108239 | |
216 | Phosphorylation | LRENEVSTLYKGEYH EECCCCCCCCCCCCC | 39.00 | 30108239 | |
218 | Phosphorylation | ENEVSTLYKGEYHRA CCCCCCCCCCCCCCC | 19.62 | 30108239 | |
219 | Ubiquitination | NEVSTLYKGEYHRAP CCCCCCCCCCCCCCC | 48.67 | 29967540 | |
222 | Phosphorylation | STLYKGEYHRAPVAI CCCCCCCCCCCCHHH | 12.79 | 30108239 | |
230 | Ubiquitination | HRAPVAIKVFKKLQA CCCCHHHHHHHHCCC | 31.70 | 29967540 | |
246 | Phosphorylation | SIAIVRQTFNKEIKT CEEEEEHHHCHHHHH | 20.72 | 20393185 | |
249 | Ubiquitination | IVRQTFNKEIKTMKK EEEHHHCHHHHHHHH | 57.54 | 29967540 | |
253 | O-linked_Glycosylation | TFNKEIKTMKKFESP HHCHHHHHHHHCCCC | 39.63 | 29237092 | |
259 | O-linked_Glycosylation | KTMKKFESPNILRIF HHHHHCCCCCHHHEE | 26.78 | 29237092 | |
302 | Phosphorylation | LDREKDLTLGKRMVL HHHHCCCCHHHHHHH | 43.53 | - | |
331 | Ubiquitination | EAPELHGKIRSSNFL CCHHHCCEEECCCEE | 24.97 | 33845483 | |
334 | Phosphorylation | ELHGKIRSSNFLVTQ HHCCEEECCCEEEEC | 32.86 | - | |
354 | Acetylation | LAGFELRKTQTSMSL ECCEEEECCCCCCCC | 58.57 | 7377595 | |
354 | Ubiquitination | LAGFELRKTQTSMSL ECCEEEECCCCCCCC | 58.57 | 24816145 | |
357 | Phosphorylation | FELRKTQTSMSLGTT EEEECCCCCCCCCCC | 31.46 | 22265413 | |
357 | O-linked_Glycosylation | FELRKTQTSMSLGTT EEEECCCCCCCCCCC | 31.46 | 29237092 | |
358 | O-linked_Glycosylation | ELRKTQTSMSLGTTR EEECCCCCCCCCCCH | 9.14 | 29237092 | |
358 | Phosphorylation | ELRKTQTSMSLGTTR EEECCCCCCCCCCCH | 9.14 | 22265413 | |
360 | Phosphorylation | RKTQTSMSLGTTREK ECCCCCCCCCCCHHH | 24.34 | - | |
364 | Phosphorylation | TSMSLGTTREKTDRV CCCCCCCCHHHCHHC | 34.72 | - | |
367 | Ubiquitination | SLGTTREKTDRVKST CCCCCHHHCHHCCCC | 53.05 | 22817900 | |
372 | Ubiquitination | REKTDRVKSTAYLSP HHHCHHCCCCEECCH | 42.87 | 21963094 | |
373 | Phosphorylation | EKTDRVKSTAYLSPQ HHCHHCCCCEECCHH | 18.53 | 23663014 | |
374 | Phosphorylation | KTDRVKSTAYLSPQE HCHHCCCCEECCHHH | 17.38 | 19276368 | |
376 | Phosphorylation | DRVKSTAYLSPQELE HHCCCCEECCHHHHH | 14.06 | 23663014 | |
378 | Phosphorylation | VKSTAYLSPQELEDV CCCCEECCHHHHHHH | 16.32 | 23663014 | |
387 | Phosphorylation | QELEDVFYQYDVKSE HHHHHHHHHCCCCHH | 13.15 | 26074081 | |
389 | Phosphorylation | LEDVFYQYDVKSEIY HHHHHHHCCCCHHEE | 16.01 | 26074081 | |
393 | Phosphorylation | FYQYDVKSEIYSFGI HHHCCCCHHEEEEEE | 29.13 | 26074081 | |
396 | Phosphorylation | YDVKSEIYSFGIVLW CCCCHHEEEEEEEEE | 8.22 | 26074081 | |
397 | Phosphorylation | DVKSEIYSFGIVLWE CCCHHEEEEEEEEEE | 23.74 | 26074081 | |
407 | Phosphorylation | IVLWEIATGDIPFQG EEEEEHHCCCCCCCC | 40.84 | 26074081 | |
417 | Phosphorylation | IPFQGCNSEKIRKLV CCCCCCCHHHHHHHH | 44.32 | 26074081 | |
454 | Phosphorylation | ECRAHDPSVRPSVDE HHHHCCCCCCCCHHH | 36.49 | 20873877 | |
458 | Phosphorylation | HDPSVRPSVDEILKK CCCCCCCCHHHHHHH | 31.47 | 20873877 | |
467 | Phosphorylation | DEILKKLSTFSK--- HHHHHHHHCCCC--- | 35.96 | 23312004 | |
468 | Phosphorylation | EILKKLSTFSK---- HHHHHHHCCCC---- | 42.22 | 23312004 | |
470 | Phosphorylation | LKKLSTFSK------ HHHHHCCCC------ | 37.23 | 23312004 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MLKL_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MLKL_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NDUB7_HUMAN | NDUFB7 | physical | 21988832 | |
RAD18_HUMAN | RAD18 | physical | 21988832 | |
THOC3_HUMAN | THOC3 | physical | 21988832 | |
CASP8_HUMAN | CASP8 | physical | 26496610 | |
GSLG1_HUMAN | GLG1 | physical | 26496610 | |
SRA1_HUMAN | SRA1 | physical | 26496610 | |
PAR16_HUMAN | PARP16 | physical | 26496610 | |
LRCH3_HUMAN | LRCH3 | physical | 26496610 | |
TRAF2_HUMAN | TRAF2 | physical | 25882049 | |
RIPK1_HUMAN | RIPK1 | physical | 27560715 | |
RIPK3_HUMAN | RIPK3 | physical | 27560715 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-125, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-125, AND MASSSPECTROMETRY. |